T1	Pharmacological_substance 43 52	gefitinib
N1000 	Reference T1 MeSH:C419708	gefitinib
T2	Pharmacological_substance 58 68	rifampicin
N1001 	Reference T2 MeSH:D012293	rifampicin
T3	Pharmacological_substance 70 82	itraconazole
N1002 	Reference T3 MeSH:D017964	itraconazole
T4	Pharmacological_substance 87 97	metoprolol
N1003 	Reference T4 MeSH:D008790	metoprolol
T5	Pharmacological_substance 102 111	Gefitinib
N1004 	Reference T5 MeSH:C419708	Gefitinib
T6	Pharmacological_substance 113 119	IRESSA
N1005 	Reference T6 MeSH:C419708	IRESSA
T7	Pharmacological_substance 121 127	ZD1839
N1006 	Reference T7 MeSH:C419708	ZD1839
T10	Disorder 262 288	non-small-cell lung cancer
N1 	Reference T10 UMLS:C0007131	non-small-cell lung cancer
T13	Pharmacological_substance 406 415	gefitinib
N1007 	Reference T13 MeSH:C419708	gefitinib
T14	Pharmacological_substance 449 458	gefitinib
N1008 	Reference T14 MeSH:C419708	gefitinib
T16	Pharmacological_substance 652 661	gefitinib
N1009 	Reference T16 MeSH:C419708	gefitinib
T17	Pharmacological_substance 701 710	gefitinib
N1010 	Reference T17 MeSH:C419708	gefitinib
T20	Subject 840 845	Human
T23	Pharmacological_substance 936 945	gefitinib
N1011 	Reference T23 MeSH:C419708	gefitinib
T24	Pharmacological_substance 1165 1174	gefitinib
N1012 	Reference T24 MeSH:C419708	gefitinib
T27	Pharmacological_substance 1219 1229	rifampicin
N1013 	Reference T27 MeSH:D012293	rifampicin
T28	Pharmacological_substance 1232 1240	rifampin
N1014 	Reference T28 MeSH:D012293	rifampin
T29	Pharmacological_substance 1257 1269	itraconazole
N1015 	Reference T29 MeSH:D017964	itraconazole
T30	Pharmacological_substance 1346 1355	gefitinib
N1016 	Reference T30 MeSH:C419708	gefitinib
T31	Pharmacological_substance 1387 1397	metoprolol
N1017 	Reference T31 MeSH:D008790	metoprolol
T36	Pharmacological_substance 1545 1554	gefitinib
N1018 	Reference T36 MeSH:C419708	gefitinib
T37	Pharmacological_substance 1564 1573	gefitinib
N1019 	Reference T37 MeSH:C419708	gefitinib
T41	Pharmacological_substance 1645 1654	gefitinib
N1020 	Reference T41 MeSH:C419708	gefitinib
T42	Pharmacological_substance 1691 1701	rifampicin
N1021 	Reference T42 MeSH:D012293	rifampicin
T45	Pharmacological_substance 1906 1915	gefitinib
N1022 	Reference T45 MeSH:C419708	gefitinib
T46	Pharmacological_substance 1952 1964	itraconazole
N1023 	Reference T46 MeSH:D017964	itraconazole
T49	Pharmacological_substance 2004 2013	gefitinib
N1024 	Reference T49 MeSH:C419708	gefitinib
T52	Pharmacological_substance 2132 2142	metoprolol
N1025 	Reference T52 MeSH:D008790	metoprolol
T53	Pharmacological_substance 2148 2157	gefitinib
N1026 	Reference T53 MeSH:C419708	gefitinib
T55	Pharmacological_substance 2192 2202	metoprolol
N1027 	Reference T55 MeSH:D008790	metoprolol
T56	Pharmacological_substance 2416 2425	gefitinib
N1028 	Reference T56 MeSH:C419708	gefitinib
T59	Pharmacological_substance 2526 2535	gefitinib
N1029 	Reference T59 MeSH:C419708	gefitinib
T60	Pharmacological_substance 2612 2621	gefitinib
N1030 	Reference T60 MeSH:C419708	gefitinib
T61	Pharmacological_substance 2636 2645	gefitinib
N1031 	Reference T61 MeSH:C419708	gefitinib
T64	Pharmacological_substance 2713 2722	gefitinib
N1032 	Reference T64 MeSH:C419708	gefitinib
T65	Pharmacological_substance 2809 2818	Gefitinib
N1033 	Reference T65 MeSH:C419708	Gefitinib
T68	Pharmacological_substance 3048 3057	gefitinib
N1034 	Reference T68 MeSH:C419708	gefitinib
T9	Pharmacological_substance 902 916	CYP substrates
T26	Subject 1274 1297	healthy male volunteers
T73	Pharmacological_substance 791 805	CYP inhibitors
T76	Disorder 1436 1449	solid tumours
N2 	Reference T76 UMLS:C0027651	solid tumours
T82	Subject 1422 1430	patients
T92	Combination 769 777	presence
T93	Combination 924 932	presence
T95	Pharmacological_substance 1203 1217	CYP3A4 inducer
N1035 	Reference T95 MeSH:D065701	CYP3A4 inducer
N1036 	Reference T95 MeSH:D065701	CYP3A4 inducer
T98	Pharmacological_substance 1203 1209;1246 1255	CYP3A4 inhibitor
N1037 	Reference T98 MeSH:D051544	CYP3A4 inhibitor
T100	Combination 1182 1190	presence
T102	Pharmacological_substance 1401 1417	CYP2D6 substrate
T103	Combination 1940 1948	presence
T104	Combination 2112 2128	Coadministration
T105	Combination 2441 2457	coadministration
T106	Pharmacological_substance 2463 2475	other agents
T108	Pharmacological_substance 2487 2502	CYP3A4 inducers
N1038 	Reference T108 MeSH:D065701	CYP3A4 inducers
T112	Pharmacological_substance 2684 2701	CYP3A4 inhibitors
N1039 	Reference T112 MeSH:D065692	CYP3A4 inhibitors
T115	Combination 2662 2678	coadministration
T119	Pharmacological_substance 3081 3098	CYP2D6 substrates
T121	Pharmacological_substance 2896 2901	drugs
N1040 	Reference T121 MeSH:D004364	drugs
T122	Combination 3061 3075	coadministered
T126	Pharmacological_substance 133 191	epidermal growth factor receptor tyrosine kinase inhibitor
